Clinical Trials Directory

Trials / Sponsors / Kymera Therapeutics, Inc.

Kymera Therapeutics, Inc.

Industry · 10 registered clinical trials — 3 currently recruiting.

StatusTrialPhaseStarted
RecruitingFirst-in-human Study of Orally Administered KT-579 in Healthy Adult Participants
Healthy Participants
Phase 12026-02-23
RecruitingA Study of KT-621 Administered Orally to Adult Participants With Moderate to Severe Eosinophilic Asthma
Eosinophilic Asthma
Phase 22026-01-28
RecruitingA Study of KT-621 Administered Orally to Participants With Moderate to Severe Atopic Dermatitis
Atopic Dermatitis
Phase 22025-11-24
CompletedSafety, PK, PD, and Clinical Activity of Orally Administered KT-621 in Adult Patients With Atopic Dermatitis (
Atopic Dermatitis
Phase 12025-04-17
CompletedFirst-in-human Study of Orally Administered KT-621 in Healthy Adult Participants
Healthy Participants Study
Phase 12024-10-22
CompletedSafety and Clinical Activity of KT-253 in Adult Patients with High Grade Myeloid Malignancies, Acute Lymphocyt
Myeloid Malignancies, Acute Lymphocytic Leukemia, Lymphomas
Phase 12023-05-15
CompletedSafety, PK/PD, and Clinical Activity of KT-413 in Adult Patients with Relapsed or Refractory B-cell NHL
Non Hodgkin Lymphoma, Diffuse Large B Cell Lymphoma, DLBCL
Phase 12022-06-13
CompletedSafety, PK, PD, Clinical Activity of KT-333 in Adult Patients With Refractory Lymphoma, Large Granular Lymphoc
Non Hodgkin Lymphoma (NHL), Peripheral T-cell Lymphoma (PTCL), Cutaneous T-Cell Lymphoma (CTCL)
Phase 12022-05-19
CompletedA Single and Multiple Ascending Dose Trial of KT-474 in Healthy Adult Volunteers and Patients With Atopic Derm
Healthy Volunteer, Atopic Dermatitis, Hidradenitis Suppurativa
Phase 12021-02-23
CompletedEvaluation of Cutaneous and Circulating Inflammatory Biomarkers in Hidradenitis Suppurativa and Atopic Dermati
Hidradenitis Suppurativa, Dermatitis, Atopic
—2020-05-28